Open | - |
Close | - |
Volume / Avg. | 1.052K / 4.662M |
Day Range | - - - |
52 Wk Range | 62.550 - 163.240 |
Market Cap | $39.604B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 56 |
Short Interest | 8.38% |
Days to Cover | 6.11 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Moderna (NASDAQ: MRNA) through any online brokerage.
Other companies in Moderna’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Cerevel Therapeutics Hldg (NASDAQ:CERE).
The latest price target for Moderna (NASDAQ: MRNA) was reported by HSBC on Monday, February 26, 2024. The analyst firm set a price target for 86.00 expecting MRNA to fall to within 12 months (a possible -17.03% downside). 26 analyst firms have reported ratings in the last year.
The stock price for Moderna (NASDAQ: MRNA) is $103.6549 last updated March 18, 2024 at 6:51 PM EDT.
There are no upcoming dividends for Moderna.
Moderna’s Q1 earnings are confirmed for Thursday, May 2, 2024.
There is no upcoming split for Moderna.
Moderna is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.